CD8A and neoplasm: It is important to note that even moderate levels of IFN-γ-producing CD8 T cell responses were induced by HER-GLP vaccine constructs (Fig. 3), they were sufficient to control tumor progression (Fig. 4A) and to protect against death (Fig. 4B).